Baylis Medical: Boston science acquired Baylis medical for $1.75 billion

Boston science announced that it had signed a final agreement to acquire Baylis Medical Company Inc. with an advance payment of US $1.75 billion. The specific price is subject to the final settlement. The acquisition will expand the coverage of Boston Scientific's electrophysiological and structural heart disease product portfolio and introduce radio frequency (RF) NRG ® Versacoross ® Atrial septal puncture platform, as well as medical leads, sheaths and expanders for left atrial access.